Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models.

The present study illustrates that CBD is a well-tolerated and effective antiseizure agent and illustrates a potential disease-modifying effect of CBD on reducing both seizure burden and associated comorbidities well after the onset of symptomatic seizures in a model of TLE.